GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.
Daga M, Ullio C, Argenziano M, Dianzani C, Cavalli R, Trotta F, Ferretti C, Zara GP, Gigliotti CL, Ciamporcero ES, Pettazzoni P, Corti D, Pizzimenti S, Barrera G.
Daga M, et al. Among authors: pizzimenti s.
Free Radic Biol Med. 2016 Aug;97:24-37. doi: 10.1016/j.freeradbiomed.2016.05.009. Epub 2016 May 14.
Free Radic Biol Med. 2016.
PMID: 27184956
Free article.